Viatris Pacira Acquisition: $1.65B Non-Opioid Pain Deal
Viatris will buy Pacira BioSciences for $36.50 a share in cash, a $1.65 billion deal built on EXPAREL and ZILRETTA. Terms, numbers and risks.
Viatris will buy Pacira BioSciences for $36.50 a share in cash, a $1.65 billion deal built on EXPAREL and ZILRETTA. Terms, numbers and risks.